Cybin to Announce Third Quarter Financial Results and Business Update on February 10, 2022
January 27 2022 - 8:35AM
InvestorsHub NewsWire
TORONTO, Canada -- January 27, 2022 -- InvestorsHub NewsWire
-- Cybin Inc. (NEO:CYBN)
(NYSE
American:CYBN) ("Cybin" or the
"Company"), a biopharmaceutical company focused on
progressing "Psychedelics to Therapeutics™" today announced that it
will report financial results for its third quarter ended December
31, 2021 on Thursday, February 10, 2022.
A conference call will be held on the same day at 8:30 a.m.
(EST) to discuss the results and recent business updates. The call
will be hosted by Doug Drysdale, Cybin's Chief Executive Officer.
Mr. Drysdale and other members of the management team will be
available to answer questions from participants following the
prepared remarks.
CONFERENCE CALL DETAILS:
An archived webcast will also be available on the Company's
Investor Relations site under the Events & Presentations
page.
About Cybin
Cybin is a leading ethical biopharmaceutical company, working with
a network of world-class partners and internationally recognized
scientists, on a mission to create safe and effective therapeutics
for patients to address a multitude of mental health issues.
Headquartered in Canada and founded in 2019, Cybin is operational
in the United States, United Kingdom and Ireland. The Company is
focused on progressing Psychedelics to Therapeutics by engineering
proprietary drug discovery platforms, innovative drug delivery
systems, novel formulation approaches and treatment regimens for
mental health disorders.
Contacts
Investors & Media:
Leah Gibson
Vice President, Investor Relations
Cybin Inc.
leah@cybin.com
Cybin (AMEX:CYBN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cybin (AMEX:CYBN)
Historical Stock Chart
From Sep 2023 to Sep 2024